Vertebral Aspergillus osteomyelitis and acute diskitis in patients with chronic obstructive pulmonary disease

Mayo Clinic Proceedings

Volumn 74, Issue 6, 1999, Pages 579-583

  Martinez, Marcos ^a,c   Lee, Augustine S ^b   Hellinger, Walter C ^c   Kaplan, Joseph ^d  

^a Department of Internal Medicine ^*  (United States)

^b Division of Infectious Diseases and Internal Medicine   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; TRIAMCINOLONE ACETONIDE;

ARTICLE; ASPERGILLUS FUMIGATUS; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DISEASE PREDISPOSITION; DISKITIS; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; OSTEOMYELITIS; RISK FACTOR;

EID: 0033030994     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/74.6.579     Document Type: Article

References (31)

1. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor of invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med, 1984; 100:345-351.
2. Khoo SH, Denning DW. Invasive aspergillosis in patients with AIDS. Clin Infect Dis. 1994;19(suppl 1):S41-S48.
3. Castelli C, Benazzo F, Minoli L, Marone P, Seghezzi R, Carlizzi CN. Axpergillus infection of the L3-L4 disc space in an immunosuppressed heart transplant patient. Spine. 1990; 15:1369-1373.
4. Karim M, Alam M, Shah AA, Ahmed R, Sheikh H. Chronic invasive aspergillosis in apparently immunocompetent hosts. Clin Infect Dis. 1997;24:723-733.
5. Karam GH, Griffin FM Jr. Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts. Rev Infect Dis. 1986:8:357-363.
6. Thommi G, Bell G, Liu J, Nugent K. Spectrum of invasive pulmonary aspergillosis in immunocompetent patients with chronic obstructive pulmonary disease. South MedJ. 1991;84:828-831.
7. Bridwell KH, Campbell JW, Barenkamp SJ. Surgical treatment of hematogenous vertebral Aspergillus osteomyelitis. Spine. 1990; 15: 281-285.
8. Lang EW, Pitts LH. Intervertebral disc space infection caused by Aspergillus fumigatus. Eur Spine J. 1996:5:207-209.
9. Bennett JE. Aspergillus species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Vol 2. 4th ed. New York, NY: Churchill Livingstone; 1995:2306-2311.
10. Sen P, Louria DB. Higher bacterial and fungal infections. In: Grieco MH, ed. Infections in the Abnormal Host. New York, NY: Yorke Medical Books; 1980:339-344.
11. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest. 1982;69:617-631.
12. Singh N, Yu VL, Rihs JD. Invasive aspergillosis in AIDS. South MedJ. 1991;84:822-827.
13. Ferris B, Jones C. Paraplegia due to aspergillosis: successful conservative treatment of two cases. J. Bone Joint Surg Br. 1985;67: 800-803.
14. Yu VL, Müder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis: results from a three-year prospective study. AmJMed. 1986;81:249-254.
15. Govender S, Rajoo R, Goga IE, Charles RW. Aspergillus osteomyelitis of the spine. Spine. 1991; 16:746-749.
16. Cortet B, Richard R, Deprez X, et al. Aspergillus spondylodiscitis: successful conservative treatment in 9 cases. J Rheumatol. 1994; 21:1287-1291.
17. Assaad W, Nuchikat PS, Cohen L, Esguerra JV, Whittier FC. Aspergillus discitis with acute disc abscess. Spine. 1994; 19:2226-2229.
18. Byrd BF III, Weiner MH, McGee ZA. Aspergillus spinal epidural abscess. JAMA. 1982;248:3138-3139.
19. Pirsch JD, Maki DG. Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow: increased susceptibility to fungal infections. Ann Intern Med. 1986; 104:619-631.
20. Barnwell PA, Jelsma LF, Raff MJ. Aspergillus osteomyelitis: report of a case and review of the literature. Diagn Microbiol Infect Dis. 1985;3:515-519.
21. Mawk JR. Erickson DL, Chou SN, Seljeskog EL. Aspergillus infections of the lumbar disc spaces: report of three cases. J Neurosurg. 1983;58:270-274.
22. Tack KJ, Rhame FS, Brown B, Thompson RC Jr. Aspergillus osteomyelitis: report of four cases and review of the literature. Am J Med. 1982;73:295-300.
23. Smeenk FW, Klinkhamer PJ, Breed W, Jansz AR, Jansveld CA. Opportunistic lung infections in patients with chronic obstructive lung disease: a side effect of inhalation corticosteroids? Ned Tijdschr Geneeskd. 1996; 140:94-98.
24. Lake KB, Browne PM, Van Dyke JJ, Ayers L. Fatal disseminated aspergillosis in an asthmatic patient treated with corticosteroids. Chest. 1983;83:138-139.
25. Conesa D, Rello J, Valles J, Mariscal D, Ferreres JC. Invasive aspergillosis: a life-threatening complication of short-term steroid treatment. Ann Pharmacother. 1995;29:1235-1237.
26. Crean JM, Niederman MS, Fein AM, Feinsilver SH. Rapidly progressive respiratory failure due to Aspergillus pneumonia: a complication of short-term corticosteroid therapy. Crit Care Med. 1992;20:148-150.
27. Fahy JV, Boushey HA. Controversies involving inhaled β-agonists and inhaled corticosteroids in the treatment of asthma. Clin Chest Med. 1995:16:715-733.
28. Kainada AK, Szefler SJ, Martin RJ, et al, Asthma Clinical Research Network. Issues in the use of inhaled glucocorticoids. Am J Respir Crit Care Med. 1996; 153:1739-1748.
29. Brattsand R, Thalen A, Roempke K, Kalistrom L, Gruvstad E. Development of new glucocorticosteroids with a very high ratio between topical and systemic activities. Eur J Respir Dis Suppl. 1982:122:62-73.
30. Denning DW, Lee JY, Hosteller JS, et al. NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis [published correction appears in Am J Med. 1994; 97:497]. Am J Med. 1994;97:135-144.
31. Sharkey PK, Rinaldi MG, Dunn JF, Hardin TC, Fetchick RJ, Graybill JR. High-dose itraconazole in the treatment of severe mycoses. Antimicrob Agents Chemother. 1991:35:707-713.